BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2545986)

  • 1. Levels of viral glycoprotein provide a dose-dependent measure of tumor cell inhibition.
    Ritzi EM; Pyo S
    Life Sci; 1989; 44(26):2041-50. PubMed ID: 2545986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
    Ritzi EM; Walthall EB
    J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative flow cytometry of mouse mammary tumor virus envelope glycoprotein (gp52): alternative measures of hormone-mediated change in a viral cell surface antigen.
    Ritzi EM
    J Virol Methods; 1992 Oct; 40(1):11-30. PubMed ID: 1331158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
    Callis AH; Ritzi EM
    Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
    Ritzi EM
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):33-42. PubMed ID: 8645615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of mouse mammary tumor virus envelope glycoprotein (Gp52) by growth factors.
    Ritzi EM; Walthall EB
    Intervirology; 1988; 29(3):144-53. PubMed ID: 2846465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect reflected by plasma levels of a viral protein during combination chemotherapeutic treatment of mammary tumor-bearing mice.
    Ritzi EM; Martin DS; Stolfi RL; Spiegelman S
    Cancer Res; 1985 Nov; 45(11 Pt 1):5374-8. PubMed ID: 3840411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of a viral protein during adjuvant treatment: reflection of murine mammary tumor status and therapeutic effect.
    Ritzi EM; Martin DS; Stolfi RL
    Cancer Res; 1986 Jun; 46(6):2804-9. PubMed ID: 3754489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative modification of dexamethasone-mediated MMTV gp52 release by progesterone pretreatment of tumor cells.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):111-6. PubMed ID: 2542181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
    Holder WD; Peer GW; Bolognesi DP; Wells SA
    Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids alter the level and distribution of mouse mammary tumor virus gp52 in vitro.
    Sunzeri FJ; Buehring GC
    Cancer Lett; 1993 Oct; 74(1-2):57-64. PubMed ID: 8287372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of a viral protein as a diagnostic signal for the presence of mammary tumor: the effect of tumor removal.
    Ritzi E; Martin DS; Stolfi RL; Spiegelman S
    J Exp Med; 1977 Apr; 145(4):999-1013. PubMed ID: 192830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glucocorticoid on the subcellular localization, oligomerization, and processing of mouse mammary tumor virus envelope protein precursor Pr74.
    Corey JL; Stallcup MR
    Mol Endocrinol; 1992 Mar; 6(3):450-8. PubMed ID: 1316542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second messengers induced by the envelope protein of a retrovirus.
    Bolander FF
    Mol Cell Endocrinol; 1997 Apr; 129(1):27-32. PubMed ID: 9175626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of a viral protein as a diagnostic signal for the presence of tumor : the murine mammary tumor model.
    Ritzi E; Martin DS; Stolfi RL; Spiegelman S
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4190-4. PubMed ID: 186789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains.
    Dusing-Swartz S; Medina D; Butel JS; Socher SH
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5360-4. PubMed ID: 228289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the mammary tumor virus envelope glycoprotein (gp52) on mouse mammary epithelial cell surface.
    Yang J; Tang R; Nandi S
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1044-50. PubMed ID: 71144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.